Skip to main content
Clinical Trials/NCT06289036
NCT06289036
Completed
Not Applicable

Predicting Prognosis in Subacute Ischemic Stroke Through Brain Perfusion and Collateral Circulation With Multimodal Imaging

The First Hospital of Hebei Medical University1 site in 1 country28 target enrollmentFebruary 1, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
The Levels of Cerebral Perfusion and Collateral Circulation in Patients With Subacute Stroke
Sponsor
The First Hospital of Hebei Medical University
Enrollment
28
Locations
1
Primary Endpoint
Modified Rankin Scale(mRS) score after 3 months of onset
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

We enrolled patients with subacute IS, associated with moderate-to-severe stenosis of the unilateral cervical internal carotid artery, who underwent 4D ASL. Perfusion levels and collateral circulation were compared between groups with favorable prognosis (modified Rankin scale [mRS] ≤ 2) and poor prognosis (mRS > 2).

Registry
clinicaltrials.gov
Start Date
February 1, 2021
End Date
December 31, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Zhiyuan Shen

MD

The First Hospital of Hebei Medical University

Eligibility Criteria

Inclusion Criteria

  • Confirmed unilateral internal carotid artery/MCA atherosclerotic stenosis/occlusion with a stenosis degree \> 50% verified through computed tomography angiography (CTA), magnetic resonance angiography (MRA), or digital subtraction angiography (DSA).
  • Presence of IS or transient ischemic attack (TIA) symptoms in the circulating blood supply area within the preceding 48 h.
  • Asymptomatic patients with no history of IS or TIA in the past 6 months.
  • Performance of 4D ASL tests during hospitalization.

Exclusion Criteria

  • Moderate-to-severe stenosis/occlusion of the contralateral internal carotid artery/middle cerebral arteries.
  • Age ≤ 18 years old.
  • Cardioembolic cerebral infarction.
  • Moyamoya disease.
  • Combined or previous cerebral hemorrhage or subarachnoid hemorrhage
  • History of previous cerebral infarction.
  • Claustrophobia or the presence of intracranial metal implants, cochlear implants, or pacemakers.

Outcomes

Primary Outcomes

Modified Rankin Scale(mRS) score after 3 months of onset

Time Frame: 3 months

mRS scores range from 0 to 6, where 0 indicates no symptoms, 3 indicates moderate disability, 4 indicates moderately severe disability, 5 indicates severe disability, and 6 indicates death. Patients were categorized into a good prognosis group (mRS ≤ 2) and a poor prognosis group (mRS \> 2).

Study Sites (1)

Loading locations...

Similar Trials